Stay updated on Nivolumab Neoadjuvant Immunotherapy Clinical Trial

Sign up to get notified when there's something new on the Nivolumab Neoadjuvant Immunotherapy Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab Neoadjuvant Immunotherapy Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    Revision: v3.5.2; no changes to study details, eligibility criteria, or user-facing content.
    Difference
    0.0%
    Check dated 2026-04-16T10:24:32.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    33 days ago
    Change Detected
    Summary
    Adds a Publications section featuring the J Clin Oncol article 'Induction Nivolumab Before Chemoradiation in High-Risk HPV-Driven Oropharynx Cancers: IMMUNEBOOST-HPV.' Publications are automatically filled from PubMed.
    Difference
    0.2%
    Check dated 2026-03-25T20:27:34.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    Page revision updated from v3.4.3 to v3.5.0.
    Difference
    0.0%
    Check dated 2026-03-18T15:54:15.000Z thumbnail image
  6. Check
    47 days ago
    Change Detected
    Summary
    Revision: v3.4.3 was added and Revision: v3.4.2 was removed.
    Difference
    0.0%
    Check dated 2026-03-11T15:25:22.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Added an explicit mention of 'Oropharynx cancer' as a study topic and added a Resources entry for the Genetic and Rare Diseases Information Center.
    Difference
    0.1%
    Check dated 2026-02-25T06:40:02.000Z thumbnail image
  8. Check
    76 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added. The government funding lapse notice (and Revision: v3.4.1) was removed.
    Difference
    0.4%
    Check dated 2026-02-11T02:00:54.000Z thumbnail image

Stay in the know with updates to Nivolumab Neoadjuvant Immunotherapy Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab Neoadjuvant Immunotherapy Clinical Trial page.